CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Progenics Pharmaceuticals, Inc. Company Snapshot
Progenics Pharmaceuticals, Inc. operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Progenics Pharmaceuticals with three other companies in this sector in the United States: Soligenix, Incorporation (2015 sales of $8.77 million of which 100% was Vaccines/BioDefense), SIGA Technologies, Inc. ($8.18 million of which 100% was Research & Development), and Acura Pharmaceuticals, Inc. ($8.59 million of which 100% was Generic Drug Products).

Sales Analysis. Sales fell dramatically in 2015: Progenics Pharmaceuticals reported sales of $8.68 million for the year ending December of 2015. This represents a sharp decrease of 80.4% versus 2014, when the company's sales were $44.38 million. The sales level in 2015 was fairly close to the level five years ago: in 2010, Progenics Pharmaceuticals had sales of $7.95 million.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Progenics Pharmaceuticals, Inc.
  Stock Performance Chart for Progenics Pharmaceuticals, Inc.
 
  Stock Data: Recent Stock Performance:
  Current Price (1/20/2017): 8.89
(Figures in U.S. Dollars)
1 Week -0.8%   13 Weeks -7.1%  
4 Weeks 60.5%   52 Weeks 105.8%  
 
Progenics Pharmaceuticals, Inc. Key Data:
  Ticker: PGNX Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 8,676,000
(Year Ending Jan 2016).
Employees: 66
  Currency: U.S. Dollars Market Cap: 622,757,310
  Fiscal Yr Ends: December Shares Outstanding: 70,051,441
  Share Type: Common Closely Held Shares: 1,164,773
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.